Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Jul 2009):

A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome.

Full Abstract

BACKGROUND AND OBJECTIVES: During the reproductive years, most of menstruating women experience symptoms of premenstrual syndrome (PMS), which is incapacitating in up to 10% of cases. According to complicated etiology, various therapeutic approaches have been proposed. Because PMS is a chronic situation, special attention should be paid to the side-effects of pharmacological interventions. Herbal medicine is a recent favorable therapeutic approach owing to fewer side-effects. We aimed to determine the effect of Ginkgo biloba L. on the symptoms of PMS. METHODS: This was a single-blind, randomized, placebo-controlled trial conducted from November 2007 to April 2008. The students with PMS, living in dormitories of a medical university (Tehran), who met the inclusion criteria entered the study. The students filled out the daily symptom rating forms in two consecutive menstrual cycles. After we verified the PMS diagnosis in 90 students, the participants were randomly assigned to experiment and placebo groups and took G. biloba L. tablets (containing 40 mg leaf extracts) or placebo three times a day from the 16th day of the menstrual cycle to the 5th day of the next cycle. Data were collected using daily symptom rating forms. RESULTS: Eighty-five (85, 94.4%) participants completed the study. The two groups were similar in terms of demographic characteristics and baseline overall severity of symptoms. After the intervention, there was a significant decrease in the overall severity of symptoms and physical and psychologic symptoms in both Ginkgo (23.68%) and placebo (8.74%) groups (p < 0.001). However, the mean decrease in the severity of symptoms was significantly more in the Ginkgo group compared to the placebo group (p < 0.001). CONCLUSIONS: G. biloba L. can reduce the severity of PMS symptoms. Further research on active ingredients and also the efficacy and safety of various doses and treatment durations of Ginkgo are required.

 

Author information

Author/s: Ozgoli, Giti (G); Selselei, Elham Alsadat (EA); Mojab, Faraz (F); Majd, Hamid Alavi (HA);

Affiliation: Nursing and Midwifery School, Shahid Beheshti University of Medical Sciences, Tehran, Iran. gozgoli(-atsign-)yahoo.com

Journal and publication information

Publication Type: Journal Article; Randomized Controlled Trial

Journal: Journal of alternative and complementary medicine (New York, N.Y.) (J Altern Complement Med), published in United States. (Language: eng)

Reference: 2009-Aug; vol 15 (issue 8) : pp 845-51

Dates: Created 2009/08/14; Completed 2009/10/29;

PMID: 19678774, status: MEDLINE (last retrieval date: 10/29/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Plant Extracts (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

5/3/1977
10/30/2007
Higher Relevance Score (100)
Lower Relevance Score (69)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index